A carregar...
Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world
OBJECTIVE: To assess the efficacy and safety of iGlarLixi (titratable fixed-ratio combination of insulin glargine (iGlar) and lixisenatide) in patients with type 2 diabetes (T2D) living in North America (NA; USA and Canada) compared with the rest of the world (RoW). RESEARCH DESIGN AND METHODS: Post...
Na minha lista:
| Publicado no: | BMJ Open Diabetes Res Care |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501856/ https://ncbi.nlm.nih.gov/pubmed/31114694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2018-000581 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|